HHS said it is pursuing alternatives to offset the potential loss of up to 48 million doses of flu vaccine -- it had planned for a supply of 100 million doses this season -- after vaccine supplier Chiron had its manufacturing license for its plant in Liverpoole, England, suspended by U.K. regulators. The immediate focus will be to make sure available doses reach the most vulnerable populations, HHS officials said in a news release. "We need the help of the public, the public health community and the medical community to make sure that the vaccine goes to those who truly need it most," the officials said. HHS said it is working with the British government and Chiron to see if there is a remedy to the situation. Chiron?s corporate headquarters are in Emeryville, Calif. -- by Cinda Becker
HHS prepares for major cut in flu vaccine supply
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.